Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,318Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Canaglu

02 23Canalia

03 1Invokana / Invokamet

04 7Invokana/Invokamet

05 1Royalty From Invokana

06 8Royalty from Invokana

07 13Tenelia

PharmaCompass

01

Brand Name : Invokana/Invokamet

Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Invokana/Invokamet

arrow
The MedTech Conference
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 795

2019 Revenue in Millions : 735

Growth (%) : 8

blank

02

Brand Name : Canalia

Teneligliptin, Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Canalia

arrow
The MedTech Conference
Not Confirmed

Teneligliptin, Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 137

2019 Revenue in Millions : 112

Growth (%) : 22

blank

03

Brand Name : Canalia

Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Canalia

arrow
The MedTech Conference
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 137

2019 Revenue in Millions : 112

Growth (%) : 22

blank

04

Brand Name : Tenelia

Teneligliptin, Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Tenelia

arrow
The MedTech Conference
Not Confirmed

Teneligliptin, Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 222

2019 Revenue in Millions : 230

Growth (%) : -4

blank

05

Brand Name : Tenelia

Teneligliptin, Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Tenelia

arrow
The MedTech Conference
Not Confirmed

Teneligliptin, Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 138

2019 Revenue in Millions : 147

Growth (%) : -6

blank

06

Brand Name : Canalia

Teneligliptin, Canagliflozin

arrow
The MedTech Conference
Not Confirmed

07

Brand Name : Tenelia

Teneligliptin, Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Tenelia

arrow
The MedTech Conference
Not Confirmed

Teneligliptin, Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 200

2020 Revenue in Millions : 220

Growth (%) : -2

blank

08

Brand Name : Canalia

Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Canalia

arrow
The MedTech Conference
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2021 Revenue in Millions : 139

2020 Revenue in Millions : 136

Growth (%) : 11

blank

09

Brand Name : Canaglu

Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Canaglu

arrow
The MedTech Conference
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 95

2019 Revenue in Millions : 75

Growth (%) : 26

blank

10

Brand Name : Canalia

Canagliflozin

arrow
The MedTech Conference
Not Confirmed

Brand Name : Canalia

arrow
The MedTech Conference
Not Confirmed

Canagliflozin

Main Therapeutic Indication : Diabetes

Currency : USD

2020 Revenue in Millions : 80

2019 Revenue in Millions : 69

Growth (%) : 16

blank